InsightfulValue
← Home

AbbVie
AbbVie

Pharma / Pharma


Press Releases

Date Press release
2025-05-01 05:45:00 June 3, 2025 Deadline: Contact The Gross Law Firm To Join Class Action Suit Against Abbv
New york , may 1, 2025 /prnewswire/ -- the gross law firm issues the following notice to shareholders of cerevel therapeutics holdings, inc. (nyse: abbv). shareholders who purchased shares of abbv during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
2025-04-29 13:18:00 Levi & Korsinsky Reminds Cerevel Therapeutics Holdings, Inc. Investors Of The Pending Class Action Lawsuit With A Lead Plaintiff Deadline Of June 3, 2025 – Abbv
New york, april 29, 2025 (globe newswire) -- levi & korsinsky, llp notifies investors in cerevel therapeutics holdings, inc. (\"cerevel therapeutics holdings, inc.\" or the \"company\") (nyse: abbv) of a class action securities lawsuit.
2025-04-29 07:45:00 Shareholders That Lost Money On Cerevel Therapeutics Holdings, Inc. (abbv) Should Contact Levi & Korsinsky About Pending Class Action - Abbv
New york, ny / access newswire / april 29, 2025 / if you suffered a loss on your cerevel therapeutics holdings, inc. (nyse:abbv) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cerevel-therapeutics-holdings-inc-lawsuit-submission-form?prid=145953&wire=1 or contact joseph e. levi, esq.
2025-04-29 07:30:00 Rinvoq® (upadacitinib) Receives U.s. Fda Approval For Giant Cell Arteritis (gca)
–      rinvoq (upadacitinib) is now the first and only oral janus kinase (jak) inhibitor approved for the treatment of gca in adults –      also known as temporal arteritis, gca is the most common vasculitis affecting adults in western countries 2 –      this marks the ninth approved indication for rinvoq in the u.s., across rheumatology, gastroenterology, and dermatology1 north chicago, ill. , april 29, 2025 /prnewswire/ -- abbvie (nyse: abbv) today announced the u.s. food and drug administration (fda) has approved rinvoq® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (gca).1 this comes after the european commission recently granted marketing authorization of rinvoq for the treatment of gca in adult patients.
2025-04-29 05:45:00 Levi & Korsinsky Reminds Cerevel Therapeutics Holdings, Inc. Investors Of The Pending Class Action Lawsuit With A Lead Plaintiff Deadline Of June 3, 2025 - Abbv
New york , april 29, 2025 /prnewswire/ -- levi & korsinsky, llp notifies investors in cerevel therapeutics holdings, inc. (\"cerevel therapeutics holdings, inc.\" or the \"company\") (nyse: abbv) of a class action securities lawsuit. class definition: the lawsuit seeks to recover losses on behalf of cerevel therapeutics holdings, inc. investors who were adversely affected by alleged securities fraud.
2025-04-28 12:44:00 U2hhcmVob2xkZXJzIFRo YXQgTG9zdCBNb25leSBP biBDZXJldmVsIFRoZXJh cGV1dGljcyBIb2xkaW5n cywgSW5jLiAoYWJidikg VXJnZWQgVG8gSm9pbiBD bGFzcyBBY3Rpb24g4oCT IENvbnRhY3QgVGhlIEdy b3NzIExhdyBGaXJtIFRv IExlYXJuIE1vcmU=
TmV3IHlvcmssIGFwcmls IDI4LCAyMDI1IChnbG9i ZSBuZXdzd2lyZSkgLS0g dGhlIGdyb3NzIGxhdyBm aXJtIGlzc3VlcyB0aGUg Zm9sbG93aW5nIG5vdGlj ZSB0byBzaGFyZWhvbGRl cnMgb2YgY2VyZXZlbCB0 aGVyYXBldXRpY3MgaG9s ZGluZ3MsIGluYy4gKG55 c2U6IGFiYnYpLg==
2025-04-28 05:45:00 U2hhcmVob2xkZXJzIE9m IENlcmV2ZWwgVGhlcmFw ZXV0aWNzIEhvbGRpbmdz LCBJbmMuIFNob3VsZCBD b250YWN0IFRoZSBHcm9z cyBMYXcgRmlybSBCZWZv cmUgSnVuZSAzLCAyMDI1 IFRvIERpc2N1c3MgWW91 ciBSaWdodHMgLSBBYmJ2
TmV3IHlvcmsgLCBhcHJp bCAyOCwgMjAyNSAvcHJu ZXdzd2lyZS8gLS0gdGhl IGdyb3NzIGxhdyBmaXJt IGlzc3VlcyB0aGUgZm9s bG93aW5nIG5vdGljZSB0 byBzaGFyZWhvbGRlcnMg b2bCoGNlcmV2ZWwgdGhl cmFwZXV0aWNzIGhvbGRp bmdzLCBpbmMuIChueXNl OiBhYmJ2KS4gc2hhcmVo b2xkZXJzIHdobyBwdXJj aGFzZWQgc2hhcmVzIG9m IGFiYnYgZHVyaW5nIHRo ZSBjbGFzcyBwZXJpb2Qg bGlzdGVkIGFyZSBlbmNv dXJhZ2VkIHRvIGNvbnRh Y3QgdGhlIGZpcm0gcmVn YXJkaW5nIHBvc3NpYmxl IGxlYWQgcGxhaW50aWZm IGFwcG9pbnRtZW50Lg==
2025-04-25 08:00:00 Q2xhc3MgQWN0aW9uIEZp bGVkIEFnYWluc3QgQ2Vy ZXZlbCBUaGVyYXBldXRp Y3MgSG9sZGluZ3MsIElu Yy4gKGFiYnYpIFNlZWtp bmcgUmVjb3ZlcnkgRm9y IEludmVzdG9ycyAtIENv bnRhY3QgTGV2aSAmIEtv cnNpbnNreQ==
TmV3IHlvcmssIG55IC8g YWNjZXNzIG5ld3N3aXJl IC8gYXByaWwgMjUsIDIw MjUgLyBpZiB5b3Ugc3Vm ZmVyZWQgYSBsb3NzIG9u IHlvdXIgY2VyZXZlbCB0 aGVyYXBldXRpY3MgaG9s ZGluZ3MsIGluYy4gKG55 c2U6YWJidikgaW52ZXN0 bWVudCBhbmQgd2FudCB0 byBsZWFybiBhYm91dCBh IHBvdGVudGlhbCByZWNv dmVyeSB1bmRlciB0aGUg ZmVkZXJhbCBzZWN1cml0 aWVzIGxhd3MsIGZvbGxv dyB0aGUgbGluayBiZWxv dyBmb3IgbW9yZSBpbmZv cm1hdGlvbjogaHR0cHM6 Ly96bGsuY29tL3BzbHJh LTEvY2VyZXZlbC10aGVy YXBldXRpY3MtaG9sZGlu Z3MtaW5jLWxhd3N1aXQt c3VibWlzc2lvbi1mb3Jt P3ByaWQ9MTQ1MDM4Jndp cmU9MSBvciBjb250YWN0 IGpvc2VwaCBlLiBsZXZp LCBlc3Eu
2025-04-25 07:43:00 QWJidmllIFJlcG9ydHMg Rmlyc3QtcXVhcnRlciAy MDI1IEZpbmFuY2lhbCBS ZXN1bHRz
UmVwb3J0cyBmaXJzdC1x dWFydGVyIGRpbHV0ZWQg ZXBzIG9mICQwLjcyIG9u IGEgZ2FhcCBiYXNpcywg YSBkZWNyZWFzZSBvZiA2 LjUgcGVyY2VudDsgYWRq dXN0ZWQgZGlsdXRlZCBl cHMgb2YgJDIuNDYsIGFu IGluY3JlYXNlIG9mIDYu NSBwZXJjZW50OyB0aGVz ZSByZXN1bHRzIGluY2x1 ZGUgYW4gdW5mYXZvcmFi bGUgaW1wYWN0IG9mICQw LjEzIHBlciBzaGFyZSBy ZWxhdGVkIHRvIGFjcXVp cmVkIGlwciZkIGFuZCBt aWxlc3RvbmVzIGV4cGVu c2XCoMKgIGRlbGl2ZXJz IGZpcnN0LXF1YXJ0ZXIg bmV0IHJldmVudWVzIG9m ICQxMy4zNDMgYmlsbGlv biwgYW4gaW5jcmVhc2Ug b2YgOC40IHBlcmNlbnQg b24gYSByZXBvcnRlZCBi YXNpcyBvciA5LjggcGVy Y2VudCBvbiBhbiBvcGVy YXRpb25hbCBiYXNpc8Kg wqAgZmlyc3QgLXF1YXJ0 ZXIgZ2xvYmFsIG5ldCBy ZXZlbnVlcyBmcm9tIHRo ZSBpbW11bm9sb2d5IHBv cnRmb2xpbyB3ZXJlICQ2 LjI2NCBiaWxsaW9uLCBh biBpbmNyZWFzZSBvZiAx Ni42IHBlcmNlbnQgb24g YSByZXBvcnRlZCBiYXNp cywgb3IgMTguMSBwZXJj ZW50IG9uIGFuIG9wZXJh dGlvbmFsIGJhc2lzOyBn bG9iYWwgc2t5cml6aSBu ZXQgcmV2ZW51ZXMgd2Vy ZSAkMy40MjUgYmlsbGlv bjsgZ2xvYmFsIHJpbnZv cSBuZXQgcmV2ZW51ZXMg d2VyZSAkMS43MTggYmls bGlvbjsgZ2xvYmFsIGh1 bWlyYSBuZXQgcmV2ZW51 ZXMgd2VyZSAkMS4xMjEg YmlsbGlvbsKgIMKgIGZp cnN0LXF1YXJ0ZXIgZ2xv YmFsIG5ldCByZXZlbnVl cyBmcm9tIHRoZSBuZXVy b3NjaWVuY2UgcG9ydGZv bGlvIHdlcmUgJDIuMjgy IGJpbGxpb24sIGFuIGlu Y3JlYXNlIG9mIDE2LjEg cGVyY2VudCBvbiBhIHJl cG9ydGVkIGJhc2lzLCBv ciAxNy4wIHBlcmNlbnQg b24gYW4gb3BlcmF0aW9u YWwgYmFzaXM7IGdsb2Jh bCB2cmF5bGFyIG5ldCBy ZXZlbnVlcyB3ZXJlICQ3 NjUgbWlsbGlvbjsgZ2xv YmFsIGJvdG94IHRoZXJh cGV1dGljIG5ldCByZXZl bnVlcyB3ZXJlICQ4NjYg bWlsbGlvbjsgY29tYmlu ZWQgZ2xvYmFsIHVicmVs dnkgYW5kIHF1bGlwdGEg bmV0IHJldmVudWVzIHdl cmUgJDQzMyBtaWxsaW9u wqAgwqAgZmlyc3QtcXVh cnRlciBnbG9iYWwgbmV0 IHJldmVudWVzIGZyb20g dGhlIG9uY29sb2d5IHBv cnRmb2xpbyB3ZXJlICQx LjYzMyBiaWxsaW9uLCBh biBpbmNyZWFzZSBvZiA1 LjggcGVyY2VudCBvbiBh IHJlcG9ydGVkIGJhc2lz LCBvciA3LjUgcGVyY2Vu dCBvbiBhbiBvcGVyYXRp b25hbCBiYXNpczsgZ2xv YmFsIGltYnJ1dmljYSBu ZXQgcmV2ZW51ZXMgd2Vy ZSAkNzM4IG1pbGxpb247 IGdsb2JhbCB2ZW5jbGV4 dGEgbmV0IHJldmVudWVz IHdlcmUgJDY2NSBtaWxs aW9uOyBnbG9iYWwgZWxh aGVyZSBuZXQgcmV2ZW51 ZXMgd2VyZSAkMTc5IG1p bGxpb24gwqAgZmlyc3Qg LXF1YXJ0ZXIgZ2xvYmFs IG5ldCByZXZlbnVlcyBm cm9tIHRoZSBhZXN0aGV0 aWNzIHBvcnRmb2xpbyB3 ZXJlICQxLjEwMiBiaWxs aW9uLCBhIGRlY3JlYXNl IG9mIDExLjcgcGVyY2Vu dCBvbiBhIHJlcG9ydGVk IGJhc2lzLCBvciAxMC4y IHBlcmNlbnQgb24gYW4g b3BlcmF0aW9uYWwgYmFz aXM7IGdsb2JhbCBib3Rv eCBjb3NtZXRpYyBuZXQg cmV2ZW51ZXMgd2VyZSAk NTU2IG1pbGxpb247IGds b2JhbCBqdXZlZGVybSBu ZXQgcmV2ZW51ZXMgd2Vy ZSAkMjMxIG1pbGxpb24g wqAgcmFpc2VzIDIwMjUg YWRqdXN0ZWQgZGlsdXRl ZCBlcHMgZ3VpZGFuY2Ug cmFuZ2UgZnJvbSAkMTEu OTkgLSAkMTIuMTkgdG8g JDEyLjA5IC0gJDEyLjI5 LCB3aGljaCBpbmNsdWRl cyBhbiB1bmZhdm9yYWJs ZSBpbXBhY3Qgb2YgJDAu MTMgcGVyIHNoYXJlIHJl bGF0ZWQgdG8gYWNxdWly ZWQgaXByJmQgYW5kIG1p bGVzdG9uZXMgZXhwZW5z ZSBpbmN1cnJlZCB5ZWFy LXRvLWRhdGUgdGhyb3Vn aCB0aGUgZmlyc3QgcXVh cnRlciAyMDI1IG5vcnRo IGNoaWNhZ28sIGlsbC4g LCBhcHJpbCAyNSwgMjAy NSAvcHJuZXdzd2lyZS8g LS3CoGFiYnZpZSAobnlz ZTphYmJ2KSBhbm5vdW5j ZWQgZmluYW5jaWFsIHJl c3VsdHMgZm9yIHRoZSBm aXJzdCBxdWFydGVyIGVu ZGVkIG1hcmNoIDMxLCAy MDI1Lg==
2025-04-25 05:45:00 TGV2aSAmIEtvcnNpbnNr eSBSZW1pbmRzIFNoYXJl aG9sZGVycyBPZiBBIExl YWQgUGxhaW50aWZmIERl YWRsaW5lIE9mIEp1bmUg MywgMjAyNSBJbiBDZXJl dmVsIFRoZXJhcGV1dGlj cyBIb2xkaW5ncywgSW5j LiBMYXdzdWl0IC0gQWJi dg==
TmV3IHlvcmsgLCBhcHJp bCAyNSwgMjAyNSAvcHJu ZXdzd2lyZS8gLS0gbGV2 aSAmwqBrb3JzaW5za3ks IGxscCBub3RpZmllcyBp bnZlc3RvcnMgaW4gY2Vy ZXZlbCB0aGVyYXBldXRp Y3MgaG9sZGluZ3MsIGlu Yy4gKFwiY2VyZXZlbCB0 aGVyYXBldXRpY3MgaG9s ZGluZ3MsIGluYy5cIiBv ciB0aGUgXCJjb21wYW55 XCIpIChueXNlOiBhYmJ2 KSBvZiBhIGNsYXNzIGFj dGlvbiBzZWN1cml0aWVz IGxhd3N1aXQuIGNsYXNz IGRlZmluaXRpb246IHRo ZSBsYXdzdWl0IHNlZWtz IHRvIHJlY292ZXIgbG9z c2VzIG9uIGJlaGFsZiBv ZiBjZXJldmVsIHRoZXJh cGV1dGljcyBob2xkaW5n cywgaW5jLiBpbnZlc3Rv cnMgd2hvIHdlcmUgYWR2 ZXJzZWx5IGFmZmVjdGVk IGJ5IGFsbGVnZWQgc2Vj dXJpdGllcyBmcmF1ZC4=
2025-04-24 12:29:00 TG9zdCBNb25leSBPbiBD ZXJldmVsIFRoZXJhcGV1 dGljcyBIb2xkaW5ncywg SW5jLihhYmJ2KT8gSm9p biBDbGFzcyBBY3Rpb24g U3VpdCBTZWVraW5nIFJl Y292ZXJ5IOKAkyBDb250 YWN0IExldmkgJiBLb3Jz aW5za3k=
TmV3IHlvcmssIGFwcmls IDI0LCAyMDI1IChnbG9i ZSBuZXdzd2lyZSkgLS0g bGV2aSAmIGtvcnNpbnNr eSwgbGxwIG5vdGlmaWVz IGludmVzdG9ycyBpbiBj ZXJldmVsIHRoZXJhcGV1 dGljcyBob2xkaW5ncywg aW5jLiAoXCJjZXJldmVs IHRoZXJhcGV1dGljcyBo b2xkaW5ncywgaW5jLlwi IG9yIHRoZSBcImNvbXBh bnlcIikgKG55c2U6IGFi YnYpIG9mIGEgY2xhc3Mg YWN0aW9uIHNlY3VyaXRp ZXMgbGF3c3VpdC4=
2025-04-24 09:00:00 Q2VyZXZlbCBUaGVyYXBl dXRpY3MgSG9sZGluZ3Ms IEluYy4gU3VlZCBGb3Ig U2VjdXJpdGllcyBMYXcg VmlvbGF0aW9ucyAtIENv bnRhY3QgTGV2aSAmIEtv cnNpbnNreSBCZWZvcmUg SnVuZSAzLCAyMDI1IFRv IERpc2N1c3MgWW91ciBS aWdodHMgLSBBYmJ2
TmV3IHlvcmssIG55IC8g YWNjZXNzIG5ld3N3aXJl IC8gYXByaWwgMjQsIDIw MjUgLyBpZiB5b3Ugc3Vm ZmVyZWQgYSBsb3NzIG9u IHlvdXIgY2VyZXZlbCB0 aGVyYXBldXRpY3MgaG9s ZGluZ3MsIGluYy4gKG55 c2U6YWJidikgaW52ZXN0 bWVudCBhbmQgd2FudCB0 byBsZWFybiBhYm91dCBh IHBvdGVudGlhbCByZWNv dmVyeSB1bmRlciB0aGUg ZmVkZXJhbCBzZWN1cml0 aWVzIGxhd3MsIGZvbGxv dyB0aGUgbGluayBiZWxv dyBmb3IgbW9yZSBpbmZv cm1hdGlvbjogaHR0cHM6 Ly96bGsuY29tL3BzbHJh LTEvY2VyZXZlbC10aGVy YXBldXRpY3MtaG9sZGlu Z3MtaW5jLWxhd3N1aXQt c3VibWlzc2lvbi1mb3Jt P3ByaWQ9MTQ0ODc4Jndp cmU9MSBvciBjb250YWN0 IGpvc2VwaCBlLiBsZXZp LCBlc3Eu
2025-04-24 08:30:00 QWJidmllIFN1Ym1pdHMg QmlvbG9naWNzIExpY2Vu c2UgQXBwbGljYXRpb24g VG8gVS5zLiBGZGEgRm9y IFRyZW5pYm90dWxpbnVt dG94aW5lICh0cmVuaWJv dGUpIEZvciBUaGUgVHJl YXRtZW50IE9mIEdsYWJl bGxhciBMaW5lcw==
4oCTdHJlbmlib3RlIGlz IGEgZmlyc3QtaW4tY2xh c3MgYm90dWxpbnVtIG5l dXJvdG94aW4gc2Vyb3R5 cGUgZSBjaGFyYWN0ZXJp emVkIGJ5IGEgcmFwaWQg b25zZXQgb2YgYWN0aW9u IGFzIGVhcmx5IGFzIDgg aG91cnMgYWZ0ZXIgYWRt aW5pc3RyYXRpb24gKGVh cmxpZXN0IGFzc2Vzc21l bnQgdGltZSkgYW5kIHNo b3J0ZXIgZHVyYXRpb24g b2YgZWZmZWN0IG9mIDIt MyB3ZWVrcy7CoCDigJMg aWYgYXBwcm92ZWQsIHRy ZW5pYm90ZSDCoHdpbGwg YmUgdGhlIGZpcnN0IG5l dXJvdG94aW4gb2YgaXRz IGtpbmQgYXZhaWxhYmxl IHRvIHBhdGllbnRzLg==
2025-04-24 05:45:00 VGhlIEdyb3NzIExhdyBG aXJtIFJlbWluZHMgQ2Vy ZXZlbCBUaGVyYXBldXRp Y3MgSG9sZGluZ3MsIElu Yy4gSW52ZXN0b3JzIE9m IFRoZSBQZW5kaW5nIENs YXNzIEFjdGlvbiBMYXdz dWl0IFdpdGggQSBMZWFk IFBsYWludGlmZiBEZWFk bGluZSBPZiBKdW5lIDMs IDIwMjUgLSBBYmJ2
TmV3IHlvcmsgLCBhcHJp bCAyNCwgMjAyNSAvcHJu ZXdzd2lyZS8gLS0gdGhl IGdyb3NzIGxhdyBmaXJt IGlzc3VlcyB0aGUgZm9s bG93aW5nIG5vdGljZSB0 byBzaGFyZWhvbGRlcnMg b2YgY2VyZXZlbCB0aGVy YXBldXRpY3MgaG9sZGlu Z3MsIGluYy4gKG55c2U6 IGFiYnYpLiBzaGFyZWhv bGRlcnMgd2hvIHB1cmNo YXNlZCBzaGFyZXMgb2Yg YWJidiBkdXJpbmcgdGhl IGNsYXNzIHBlcmlvZCBs aXN0ZWQgYXJlIGVuY291 cmFnZWQgdG8gY29udGFj dCB0aGUgZmlybSByZWdh cmRpbmcgcG9zc2libGUg bGVhZCBwbGFpbnRpZmYg YXBwb2ludG1lbnQu
2025-04-23 13:25:00 Q2VyZXZlbCBUaGVyYXBl dXRpY3MgSG9sZGluZ3Ms IEluYy4gU3VlZCBGb3Ig U2VjdXJpdGllcyBMYXcg VmlvbGF0aW9ucyDigJMg SW52ZXN0b3JzIFNob3Vs ZCBDb250YWN0IFRoZSBH cm9zcyBMYXcgRmlybSBC ZWZvcmUgSnVuZSAzLCAy MDI1IFRvIERpc2N1c3Mg WW91ciBSaWdodHMg4oCT IEFiYnY=
TmV3IHlvcmssIGFwcmls IDIzLCAyMDI1IChnbG9i ZSBuZXdzd2lyZSkgLS0g dGhlIGdyb3NzIGxhdyBm aXJtIGlzc3VlcyB0aGUg Zm9sbG93aW5nIG5vdGlj ZSB0byBzaGFyZWhvbGRl cnMgb2YgY2VyZXZlbCB0 aGVyYXBldXRpY3MgaG9s ZGluZ3MsIGluYy4gKG55 c2U6IGFiYnYpLg==
AbbVie

Browse additional press releases for AbbVie!

Sign up for free or log in
© 2024 - 2025 InsightfulValue.com. All rights reserved. Legal